Washington University School of Medicine
St Louis, Missouri, 63110, United States
Location contact
Cassandra Fritz, MD, MPHS
CONTACT
Darren Nix
CONTACT
Kamilah Scales, MD
SUB_INVESTIGATOR
NCT Number: NCT07781774
This is a mixed-methods implementation pilot combining an educational intervention with a mailed stool-based testing outreach feasibility study within a resident primary care clinic. Participants will be assigned by clinic team to education, mailed FIT, mailed Cologuard, or usual care comparison groups.
Trial opening soon.
Get Notified45 year–75 year
All sexes
Interventional
Not applicable
St Louis, Missouri, 63110, United States
Cassandra Fritz, MD, MPHS
CONTACT
Darren Nix
CONTACT
Kamilah Scales, MD
SUB_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Phase 1 Education Arm Inclusion Criteria:
Phase 1 Education Arm Exclusion Criteria:
Phase 2 (All Other Arms) Inclusion Criteria:
Phase 2 (All Other Arms) Exclusion Criteria:
Education materials are compiled from the American College of Gastroenterology (ACG) and the City of Hope. The education materials are at a 6th grade reading level. Materials detail digestive system and polyp background, colorectal cancer (CRC) risk factors, warning signs, screening options, recommended initial screening age, and stool-based screening and colonoscopy processes.
The Cologuard test will be mailed to the participants. Participants will complete the test via the step-by-step written and pictorial instructions provided and mail the complete test with the pre-paid return label provided.
The Fecal immunochemical test (FIT) will be mailed to the participants. Participants will complete the test via the step-by-step written and pictorial instructions provided and mail the complete test with the pre-paid return label provided.
Usual care for patients eligible for colorectal cancer screening will be provided by the Barnes-Jewish Hospital Primary Care Medicine Clinic.
Time frame: At enrollment and 3 months after educational intervention (total estimated time is 3 months)
Change in CRC knowledge will be measured by changes in the score of the Assessment of Colon Cancer Literacy (ACCL) test. The ACCL consists of 10-items with True/False/Unsure. The ACCL score ranges from 0 to 10 with a score of 7-10 indicating adequate literacy and scores of 0-6 indicating limited literacy.
Time frame: At 3 months after receiving kit (total estimated time 3 months)
Time frame: At completion of testing or at 3 months after receiving test kit (total estimated time 3 months)
Acceptability will be assessed using the 3-item Customer Service Questionnaire (CSQ-3). The 3-items are rated on a 4-point Likert scale as follows: 1=Poor, 2=Fair, 3=Good, and 4=Excellent. Generally, the higher the score indicates greater customer satisfaction.
Time frame: From time of receiving CRC kit to 6 months after receiving kit (total estimated time 6 months)
CRC screening completion rate will be assessed through electronic health record (EHR) verification of screening completion.
Contact information is provided by the study sponsor or research team.
Cassandra Fritz, MD, MPHS
CONTACT
Darren Nix
CONTACT
Washington University School of Medicine
Other
Improving Colorectal Cancer Screening Uptake Through Patient-Centered Education and Mailed Stool-Based Testing Outreach in the Primary Care Medicine Clinic
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07398456
Colonic Diseases, Colorectal Cancer (CRC) Screening
Dallas, Texas, United States
View Trial DetailsNCT06612281
Colonic Diseases, Colorectal Adenoma
Portland, Oregon, United States
View Trial DetailsNCT02387268
Colonic Diseases, Colorectal Cancer (CRC) Screening
View Trial DetailsNCT07011576
Colon Cancer, Colonic Diseases
Denver, Colorado, United States
View Trial Details